argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally. The company offers VYVGART for the treatment of g...
Leadership
Timothy Van Hauwermeiren EMBA, M.Sc.Founder
Co-Founder & Non-Independent Non-Executive Chairman of the Board
Karen Massey
CEO & Executive Director
Karl Gubitz
Chief Financial Officer
Peter Ulrichts
Chief Scientific Officer
Malini Moorthy
General Counsel & Corporate Secretary
Arjen Lemmen M.Sc.
Vice President of Corporate Development & Strategy
